IS

Ismil Suleman Memon

Director Director DIN 07097980
DIN 07097980 First appointment May 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2015
Shareholding value Locked Premium profile

About Ismil Suleman Memon

Ismil Suleman Memon has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 07097980
Primary Designation Director
First Appointment 12 May 2015
Oldest Company Age 11 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Hellys Pharmaceuticals Private Limited U24230GJ2015PTC083178
Director 12 May 2015 2015 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hellys Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ismil Suleman Memon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ismil Suleman Memon

Ismil Suleman Memon has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ismil Suleman Memon is associated with 0 companies as Director.

Ismil Suleman Memon has expertise in General Business.

Ismil Suleman Memon has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available